The annual percentage increase in total kidney volume was significantly lower in the low-blood-pressure group than in the standard-blood-pressure group ( 5.6 % vs. 6.6 % , P = 0.006 ) , without significant differences between the lisinopril-telmisartan group and the lisinopril-placebo group .